01Principles and purposeThe professional or clinical skill and the decisions it supports.
Surgery can combine venous stasis, vascular injury and a prothrombotic inflammatory response. Immobility may persist after discharge, while cancer and previous thrombosis can add risk. Prophylaxis aims to prevent a first postoperative event during this vulnerable period. Its benefit must be weighed against bleeding into the operation site or another vulnerable space. The same patient can be at high risk of both outcomes, so a high VTE score does not automatically justify immediate anticoagulant administration before haemostasis is secure.
The decision has several independent parts: whether prophylaxis is indicated, which method to use, when to begin, whether the dose fits the patient, and when to stop. Completing a risk form answers none of these by itself. A useful plan explains why pharmacological prophylaxis is given or withheld, whether a mechanical method is appropriate, and what change will trigger reassessment. A temporary contraindication should produce a timed review rather than permanent omission from the drug chart.
NICE NG89 provides procedure-specific recommendations. In abdominal surgery, start an appropriate mechanical method on admission after contraindication and fit checks, while pharmacological prevention is added when thrombosis risk exceeds bleeding risk. A minimum seven-day course is different from the twenty-eight-day extension considered after major abdominal cancer surgery. Other operations have their own recommendations; do not transfer the abdominal schedule automatically to every orthopaedic, vascular or minor operation. Product information then supplies the medicine-specific regimen and precautions rather than determining the whole clinical indication.
Key points
- Assess venous thromboembolism and bleeding risk together, then reassess when the clinical situation changes.
- For abdominal surgery, add pharmacological prophylaxis when VTE risk outweighs bleeding risk, for at least seven days.
- Consider twenty-eight postoperative days of pharmacological prophylaxis after major abdominal cancer surgery.
- Mechanical prophylaxis needs correct selection, fitting and skin checks; it is not harmless in every patient.
- Enoxaparin doses depend on indication, renal function, body size, bleeding risk and neuraxial arrangements.
- A new symptom suggesting DVT or pulmonary embolism requires diagnostic assessment, not merely a prophylactic dose.
02Situations and prioritiesThe context, relevant information and actions that matter most.
Previous VTE, active cancer and markedly reduced mobility make the prophylaxis decision especially important. Clarify timing and treatment of any previous event. A patient still taking therapeutic anticoagulation needs a coordinated interruption or continuation plan rather than an additional automatic prophylactic prescription.
Active haemorrhage, a concerning postoperative haemoglobin trend or the prospect of urgent reoperation may make immediate anticoagulant prophylaxis unsafe. Escalate to the responsible surgical team, document the reason for withholding and set a reassessment point; consider an appropriate mechanical method while risk is reviewed.
Spinal or epidural procedures introduce a separate timing constraint because bleeding into the spinal canal can cause severe neurological harm. Confirm insertion and removal plans with anaesthesia before prescribing or administering anticoagulants. An ordinary ward dose time must not override the neuraxial plan.
New unilateral leg swelling, unexplained hypoxaemia, pleuritic pain or collapse may represent VTE even when prescribed doses were given. Assess the patient urgently according to the presentation and seek diagnostic and treatment decisions. Prophylactic dosing neither excludes nor treats an established event.
03Assessment and interpretationHow to gather information, assess the situation and recognise uncertainty.
Consider the information, its meaning and its limitations before deciding what follows.
- 01
Assess both competing risks - Why
- Identify the factors that change the likely benefit and harm of prophylaxis.
- Interpretation and limitations
- Use the approved risk tool alongside the operation, mobility, history and current haemostasis. A tool standardises prompts but does not know that the surgeon expects reoperation tonight unless that information is supplied.
- 02
Check renal function and body size - Why
- Ensure the selected anticoagulant regimen is suitable for the patient.
- Interpretation and limitations
- Review current renal function rather than a distant baseline, particularly after dehydration or perioperative kidney injury. Extremes of body weight may require a locally specified adjustment or specialist advice. Do not confuse prophylactic regimens with weight-based therapeutic treatment.
- 03
Review platelets and relevant medicine history - Why
- Identify thrombocytopenia, prior heparin-induced thrombocytopenia and additional bleeding risks.
- Interpretation and limitations
- A history of immune-mediated HIT changes the choice of anticoagulant. Concomitant antiplatelets, anticoagulants and some analgesics can increase bleeding. Interpret an abnormal platelet count in context and follow specialist advice where the balance is difficult.
- 04
Inspect suitability of a mechanical method - Why
- Select a device the patient can safely use and that will actually be applied.
- Interpretation and limitations
- Check limb circulation, skin integrity, sensation, swelling and fit. Anti-embolism stockings are unsuitable in some arterial or skin conditions. Intermittent pneumatic compression has practical requirements, and a device left disconnected provides little protection regardless of its documentation.
04Worked approachesCases with ordered reasoning, an action and a check of the outcome.
01Worked casePlanning prophylaxis beyond dischargeA 67-year-old weighing 78 kg undergoes major elective abdominal cancer resection. Creatinine clearance is 78 mL/min, there is no HIT history or active bleeding, no neuraxial catheter is planned, and reduced mobility is expected. The proposed discharge prescription contains only three further days of prophylaxis.+
- 1Confirm that VTE risk outweighs bleeding risk in the current postoperative state. Cancer, major abdominal surgery and reduced mobility support prevention, but review haemostasis and the possibility of another procedure before treating the risk score as sufficient.
- 2Check which locally approved prophylactic medicine and mechanical method apply. If enoxaparin is selected for this high-risk adult with the stated renal function and body size, the product-specific example is 40 mg subcutaneously once daily, with perioperative timing agreed against haemostasis and the operative plan.
- 3Consider the NG89 recommendation to extend pharmacological prophylaxis to twenty-eight days after major abdominal cancer surgery. Count the postoperative days already covered and calculate the remaining supply; discharge is a location change, not necessarily the end of thrombotic risk.
- 4Agree the duration and prescription with the responsible clinician, document the end date and check practical administration. Teach injection technique, provide the correct product and sharps arrangements, and establish who can help if the patient cannot inject independently.
- 5Verify that the patient can explain the daily plan, the stopping date and when to seek help for bleeding or possible thrombosis. Recheck renal function and medication changes if clinical circumstances alter before or after discharge.
02Temporary bleeding riskWithholding a dose without losing the prevention planA patient after abdominal surgery develops fresh drain bleeding and may need re-exploration.+
- 1Assess the bleeding and escalate promptly. Review the next anticoagulant dose with the surgical team rather than administering it because it appears on a routine chart.
- 2Document the reason for withholding and assess whether mechanical prophylaxis is appropriate. Name the clinician or team responsible for reassessment after haemostasis or operative review.
- 3Restart pharmacological prevention when the balance becomes favourable, using an updated renal, bleeding and neuraxial assessment. Do not allow a one-off hold to become an unexplained omission for the rest of admission.
03Mechanical preventionMaking the prescribed device effectiveA patient cannot currently receive anticoagulant prophylaxis and has been prescribed a mechanical device.+
- 1Confirm that the chosen method is suitable for limb perfusion, skin condition and the operation. Choose an alternative through the appropriate team if stocking or device contraindications are present.
- 2Fit and apply it correctly, explain its purpose and arrange skin and device checks. Ask why it is removed or disconnected rather than labelling the patient non-compliant without understanding discomfort or practical barriers.
- 3Reassess mobility and bleeding risk and update the plan. A mechanical prescription is not a reason to stop considering pharmacological prophylaxis when the temporary contraindication resolves.
05Relevant medicines and safetySpecific regimens and precautions when the skill involves prescribing.
Enoxaparin sodium: high-risk adult surgical prophylaxis
Inhixa product example: 4,000 IU anti-Xa (40 mg) subcutaneously once daily for a high-risk surgical adult. Its SmPC prefers starting 12 hours before surgery. Use the operation-specific duration: for qualifying abdominal surgery at least 7 days under NICE NG89, with 28 postoperative days considered after major abdominal cancer surgery. Agree postoperative timing with haemostasis and the anaesthetic plan.Check active bleeding, prior immune-mediated HIT, platelet status, renal function, weight and concurrent antithrombotics. In creatinine clearance 15–30 mL/min, the Inhixa prophylaxis regimen is 20 mg subcutaneously once daily; below 15 mL/min it is not recommended outside the haemodialysis indication. Neuraxial timing requires a separate anaesthetic plan. Do not administer intramuscularly or substitute a therapeutic dose.
06Feedback, follow-up and evidenceReview outcomes, seek feedback and identify what to improve.
- Reassess VTE and bleeding risk after surgery, deterioration, a change in mobility or a major medicine change. The balance can reverse within hours, especially around haemorrhage and reoperation.
- Check that prescribed doses were actually administered and investigate omissions. A prescription history can look complete while the patient repeatedly declines injections or the medicine is unavailable.
- Monitor for clinically important bleeding, falling platelets where indicated, renal deterioration and device-related skin injury. Review the regimen promptly rather than waiting for a routine discharge reconciliation.
- At discharge, give an explicit duration, remaining supply, administration support and advice about possible DVT, pulmonary embolism and significant bleeding. Communicate responsibility for any planned review or laboratory check.
07Special situationsVariants, exceptions and circumstances that change the usual approach.
Porcine origin and informed choice
Enoxaparin is derived from porcine material. If this matters to the patient, explain the source and discuss appropriate alternatives with the team. Do not assume either acceptance or refusal from a person’s background, and avoid leaving them without an agreed prevention plan.
Therapeutic anticoagulation is a different task
A patient treated for atrial fibrillation or recent VTE may need a perioperative interruption strategy. Adding LMWH without checking whether the regular anticoagulant continues can create duplication. Postoperative prophylaxis and therapeutic bridging address different indications and use different doses.
Same-day surgery
A short stay does not by itself settle VTE risk. Consider the procedure, anaesthesia, mobility and patient-specific factors under the relevant recommendations. Conversely, a hospital visit alone does not justify anticoagulating every patient undergoing a minor intervention.
An extended course is an operational commitment
The benefit of a longer course depends on access and administration. Check manual dexterity, vision, language, housing and help at home. Solving these issues before discharge is part of prescribing rather than an optional nursing detail.
08Common pitfallsFrequent interpretation and management errors.
- 01
Treating a high VTE score as permission to administer anticoagulant during active surgical bleeding.
- 02
Stopping a planned extended course solely because the patient has left hospital and can walk a short distance.
- 03
Using a standard enoxaparin dose without reviewing new renal impairment or the neuraxial catheter plan.
- 04
Confusing a prophylactic dose with adequate treatment when symptoms suggest an established clot.